Asthma is increasingly recognised as a heterogeneous disease, with several phenotypes defined by clinical and inflammatory characteristics. Common phenotypes include allergic (eosinophilic, IgE-mediated), non-allergic (often neutrophilic or paucigranulocytic), late-onset adult asthma, obesity-associated asthma, and asthma with persistent airflow limitation.14 Identifying phenotypes supports individualised treatment strategies, particularly in those with severe asthma, and better long-term outcomes.
Steps 2 and 3: Maintenance and reliever therapy (MART)
Comorbid conditions can complicate asthma management. Assess for and help address factors such as allergic rhinitis, which affects up to 80% of people with asthma,24 as well as gastro-oesophageal reflux disease (GORD), anxiety, depression, obstructive sleep apnoea and smoking.
COVID-19 prophylactic treatment now accessible in community pharmacies
Previously available in hospitals only, Evusheld can now be accessed in Victoria's 24-hour Supercare pharmacies.
Wound infections: identification, prevention and management
Wound infection is a challenging part of wound care management, and systemic antibiotics are commonly prescribed for infection.
Hospital pharmacists: what they are doing now
Hospital pharmacists working in the hospital setting were once limited to the dispensary. This has now evolved further to specialisations.
Pharmacists in Aboriginal health services
Pharmacists who want to make a difference to the lives of Indigenous patients need to listen and learn what is important to them, says Northern Territory pharmacist Jaimee Anderson MPS.
How pharmacists can expedite diagnosis of child brain cancer
A paediatric oncologist explains how pharmacists can spot the early warning signs of childhood brain cancer and save lives.
Bridging NIPVIP knowledge gaps
For those who were unable to make it to the PSA’s jam-packed NIPVIP webinar, here’s the most sought-after information from the expert hosts.
